IMRT features in £21m round of Scottish radiotherapy capacity and upgrade programme
This article was originally published in Clinica
Scotland is investing almost £21m ($30m) in radiotherapy equipment over the next year, in a bid to ensure its five cancer centres are "at the cutting edge" of the technology. This year's round of the Radiotherapy Equipment Programme (REP) features intensity-modulated radiation therapy (IMRT) units to provide "high-precision radiotherapy" using computer-controlled X-ray accelerators (Linacs) to precisely target the tumour, or specific areas of it. The approval of the REP's 2009-10 capacity and upgrade investment was announced by Scottish health secretary Nicola Sturgeon today at Edinburgh's Western General hospital, which has received brachytherapy equipment and Linacs through the REP.
You may also be interested in...
Celltrion has accelerated the development of its antiviral treatment for COVID-19 and aims to launch a rapid self-testing kit that could provide results within 15-20 minutes. The Korean firm also plans to develop a ‘super antibody’ to prepare for potential future pandemic situations.
Paracetamol, acetylcysteine and loperamide among list of OTC drugs deemed "essential" by Spain in the fight against coronavirus.
Mylan, in partnership with Indian firm Lupin, will be looking to rival Biogen and Sandoz by introducing an etanercept biosimilar in European markets following a positive opinion by the EMA’s CHMP on Mylan's application.